Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 19, Issue 4, Pages 337-353
Publisher
Informa UK Limited
Online
2018-02-10
DOI
10.1080/14656566.2018.1439920
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of Efficacy of Difluprednate 0.05% and Loteprednol Gel 0.5% After Cataract Surgery
- (2017) Bryan Abessi et al. Eye & Contact Lens-Science and Clinical Practice
- Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure
- (2016) John D. Sheppard et al. ADVANCES IN THERAPY
- Allergic manifestations of contact lens wearing
- (2016) Abraham Solomon Current Opinion in Allergy and Clinical Immunology
- Loteprednol Etabonate 0.5%/Tobramycin 0.3% Compared with Dexamethasone 0.1%/Tobramycin 0.3% for the Treatment of Blepharitis
- (2016) Timothy L. Comstock et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Efficacy of olopatadine hydrochloride 0.1%, emedastine difumarate 0.05%, and loteprednol etabonate 0.5% for Chinese children with seasonal allergic conjunctivitis: a randomized vehicle-controlled study
- (2016) Rui-fen Liu et al. International Forum of Allergy & Rhinology
- Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty
- (2015) Marianne O. Price et al. CORNEA
- Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation
- (2015) Grace E. Boynton et al. CORNEA
- Effects of Topical Loteprednol Etabonate on Tear Cytokines and Clinical Outcomes in Moderate and Severe Meibomian Gland Dysfunction: Randomized Clinical Trial
- (2014) Hun Lee et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Effect of Loteprednol Etabonate 0.5% on Initiation of Dry Eye Treatment With Topical Cyclosporine 0.05%
- (2014) John D. Sheppard et al. Eye & Contact Lens-Science and Clinical Practice
- Loteprednol Etabonate Ophthalmic Gel 0.5% Following Cataract Surgery: Integrated Analysis of Two Clinical Studies
- (2013) Rajesh K. Rajpal et al. ADVANCES IN THERAPY
- Prolonged Exposure to Loteprednol Etabonate in Human Tear Fluid and Rabbit Ocular Tissues Following Topical Ocular Administration of Lotemax Gel, 0.5%
- (2013) Shellise Glogowski et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Loteprednol Etabonate Suspension 0.2% Administered QID Compared With Olopatadine Solution 0.1% Administered BID in the Treatment of Seasonal Allergic Conjunctivitis: A Multicenter, Randomized, Investigator-Masked, Parallel Group Study in Chinese Patients
- (2012) Lan Gong et al. CLINICAL THERAPEUTICS
- A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis
- (2012) Minjie Chen et al. CURRENT MEDICAL RESEARCH AND OPINION
- Topical loteprednol etabonate 0.5 % for treatment of vernal keratoconjunctivitis: efficacy and safety
- (2012) Veysi Öner et al. JAPANESE JOURNAL OF OPHTHALMOLOGY
- Efficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgery
- (2012) Rajesh K. Rajpal et al. JOURNAL OF CATARACT AND REFRACTIVE SURGERY
- Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery
- (2012) Stephen S. Lane et al. JOURNAL OF CATARACT AND REFRACTIVE SURGERY
- Safety and Tolerability of Loteprednol Etabonate 0.5% and Tobramycin 0.3% Ophthalmic Suspension in Pediatric Subjects
- (2012) Timothy L. Comstock et al. PEDIATRIC DRUGS
- Management of seasonal allergic conjunctivitis: guide to therapy
- (2011) Brett P. Bielory et al. ACTA OPHTHALMOLOGICA
- Topical Loteprednol Pretreatment Reduces Cyclosporine Stinging in Chronic Dry Eye Disease
- (2010) John D. Sheppard et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Attenuation of Ocular Hypertension With the Use of Topical Loteprednol Etabonate 0.5% in Steroid Responders After Corneal Transplantation
- (2009) Edward J Holland et al. CORNEA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now